BALDARI, Sergio
 Distribuzione geografica
Continente #
EU - Europa 11.194
NA - Nord America 10.262
AS - Asia 2.818
Continente sconosciuto - Info sul continente non disponibili 24
SA - Sud America 14
AF - Africa 10
OC - Oceania 10
Totale 24.332
Nazione #
US - Stati Uniti d'America 10.244
IE - Irlanda 3.068
SE - Svezia 2.879
IT - Italia 2.861
CN - Cina 1.700
DE - Germania 582
UA - Ucraina 483
SG - Singapore 446
FI - Finlandia 400
IN - India 372
GB - Regno Unito 340
VN - Vietnam 236
FR - Francia 192
PL - Polonia 116
BE - Belgio 94
CZ - Repubblica Ceca 48
RU - Federazione Russa 37
AT - Austria 36
IR - Iran 27
EU - Europa 19
NL - Olanda 19
CA - Canada 16
CL - Cile 12
TR - Turchia 12
CH - Svizzera 10
AU - Australia 9
RO - Romania 9
ES - Italia 8
AL - Albania 5
A1 - Anonimo 3
HK - Hong Kong 3
IL - Israele 3
A2 - ???statistics.table.value.countryCode.A2??? 2
BD - Bangladesh 2
DZ - Algeria 2
EG - Egitto 2
ID - Indonesia 2
IQ - Iraq 2
JP - Giappone 2
MA - Marocco 2
MU - Mauritius 2
PH - Filippine 2
TH - Thailandia 2
TN - Tunisia 2
AE - Emirati Arabi Uniti 1
AZ - Azerbaigian 1
BG - Bulgaria 1
BR - Brasile 1
EE - Estonia 1
HR - Croazia 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LT - Lituania 1
MK - Macedonia 1
MN - Mongolia 1
MX - Messico 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
PA - Panama 1
PE - Perù 1
PT - Portogallo 1
SA - Arabia Saudita 1
TW - Taiwan 1
Totale 24.332
Città #
Dublin 3.066
Chandler 2.474
Nyköping 1.666
Jacksonville 1.173
Beijing 724
Ashburn 607
Princeton 508
Medford 474
Dearborn 406
Cambridge 365
Des Moines 351
Ann Arbor 337
Messina 269
Singapore 252
Dong Ket 236
Boardman 226
Milan 221
Hyderabad 212
New York 197
Rome 177
Bremen 164
Jinan 149
Lancaster 145
Wilmington 138
Shenyang 121
Pune 117
Warsaw 110
Woodbridge 99
San Mateo 91
Brussels 90
Naples 85
Nanjing 74
Los Angeles 72
Catania 64
Zhengzhou 59
Hebei 52
Houston 52
Palermo 51
Tianjin 51
Ningbo 50
Nanchang 49
Turin 47
Brno 43
Helsinki 43
Hangzhou 42
Seattle 42
Genoa 41
Haikou 40
Bari 36
Taizhou 36
Vienna 34
Munich 33
Guangzhou 32
Fuzhou 30
Norwalk 30
Washington 30
Augusta 28
Changsha 26
Trieste 26
Florence 25
Lanzhou 23
Bologna 22
Jiaxing 20
Falls Church 19
Mumbai 19
Brescia 18
Monmouth Junction 18
Ardabil 17
Leawood 17
Redwood City 17
Bergamo 16
Pisa 16
Taiyuan 16
Clearwater 15
Parma 15
Cagliari 14
Verona 14
Santa Clara 12
Strasbourg 12
Auburn Hills 10
Cosenza 10
Padova 9
Pescara 9
Cascina 8
Comiso 8
Prato 8
Amsterdam 7
Ancona 7
Clifton 7
Eboli 7
Hefei 7
Napoli 7
Reggio Calabria 7
Saint Petersburg 7
Vittoria 7
Aversa 6
Ferrara 6
Kunming 6
Modugno 6
Novokuznetsk 6
Totale 16.963
Nome #
LA LOCALIZZAZIONE ISTMICA DEL NODULO TIROIDEO MALIGNO RAPPRESENTA UN FATTORE ADDIZIONALE DI RISCHIO PER METASTASI IN PAZIENTI AFFETTI DA CARCINOMA DIFFERENZIATO DELLA TIROIDE (CDT) A BASSO RISCHIO 1.947
EMIAGENESIA TIROIDEA, MORBO DI BASEDOW-GRAVES E CARCINOMA DIFFERENZIATO DELLA TIROIDE: UN’ASSOCIAZIONE MOLTO RARA. 185
Transthyretin-Related Familial Amyloid Polyneuropathy (TTR-FAP): A Single-Center Experience in Sicily, an Italian Endemic Area 113
Ruolo della scintigrafia con HIG 99mTc (immunoglobuline policlonali marcate) nella colite ulcerosa e nel morbo di Crohn. Risultati preliminari 105
131I Radioiodine therapy (RIT) of hyperthyroidism due to Graves' disease (GD) or uni-multinodular toxic goiter (NTG): our experience 100
99mTc-Methoxy-Isobutyl-Isonitrile Scintigraphy Is a Useful Tool for Assessing the Risk of Malignancy in Thyroid Nodules with Indeterminate Fine-Needle Cytology 99
111In-Pentetreotide in neuroendocrine tumours: comparison between diagnostic scintigraphy and “post-therapy” whole-body scan 97
The SAMDOCET study: 153Sm-EDTMP and Docetaxel versus Docetaxel in Taxane-naïve patients with metastatic castration-refractory prostate cancer. 97
111In-Pentetreotide for treatment of neuroendocrine tumours: an alternative therapeutic option in particular cases 96
Combined diagnosis in breast carcinoma: preoperative role of mammoscintigraphy with Tc99m-sestamibi. Our Experience 95
111In-Pentetreotide in neuroendocrine tumours. Comparison between diagnostic scintigraphy and “post-therapy” whole-body scan 95
111In-Pentetreotide therapy in patients with inoperable benign intracranial tumors. 90
Abscesualized gliomas:predictive value of 99Tc-Leukoscan 89
Supra-Acetabular Brown Tumor due to Primary Hyperparathyroidism Associated with Chronic Renal Failure 88
PRRT Retreatments: Renal Function Evaluation 88
Aggressive pituitary adenomas: the dark side of the moon 87
SPECT and MRI in Complex Partial Epilepsy. 86
11C-Choline PET/CT based helical tomotherapy as innovative treatment approach for bone metastases in prostate cancer patients 85
La Chirurgia Radioimmunoguidata (R.I.G.S.) nel carcinoma del colon-retto. Risultati preliminari [Radioimmunoguided surgery (R.I.G.S.) in colorectal cancer. Preliminary results] 84
Association of autonously functioning ("hot") thyroid nodules with Hashimotos' thyroiditis (HT). 83
Modern applications of SPECT in cerebrvascular diseases 82
131I RADIOIODINE THERAPY (RIT) OF HYPERTYROIDISM DUE TO GRAVES’ DISEASE (GD) OR UNI-MULTINODULAR TOXIC GOITER (NTG): OUR EXPERIENCE 82
An analytical model for improving absorbed dose calculation accuracy in non spherical autonomous functioning thyroid nodule 81
Brunner's adenoma, esophageal reflux and gastric ulcer. A case report 80
Absorbed fractions for electrons in ellipsoidal volumes 80
Prognostic Validity of Dual Tracer PET/CT in the PRRT Enrollment of GEP-NET Patients 79
Abnormal 99mTc-MIBI Uptakein left lung mimicking a neoplastic lesion in a young woman with nodular goiter. A rare pitfall of 99mTc-MIBI 78
Radiometabolic therapy with 131I for the ablation of the thyroid remnant in patients affected by differentiated thyroid cancer: comparison between four different activities 77
Usefulness of four dimensional (4D) PET/CT imaging in the evaluation of thoracic lesions and in radiotherapy planning: Review of the literature 77
Coronary-subclavian steal phenomenon late after coronary artery bypass grafting: an underappreciated cause of myocardial ischemia? 76
ACCUMULO DI TECNEZIO IN METASTASI POLMONARI DA CARCINOMA DIFFERENZIATO TIROIDEO (CDT): UNA RARA EVENIENZA 75
Resolution of anorexia and resultant weight gain in non organic failure to thrive after domperidone therapy 74
99mTc MIBI SPET in revealing underlying neoplasms in brain hemorrhages 74
Association of parathyroid carcinoma and thyroid disorders: A clinical review 74
99mTc-MIBI SPECT in distinguishing neoplastic from nonneoplastic intracerebral hematoma 73
Evaluation of absorbed fractions for beta-gamma radionuclides in ellipsoidal volumes of soft tissue through Geant4 72
Internal Dosimetry of Ellipsoidal Targets: models and applications 72
Serial scanning with 99mTc-3, 3-diphosphono-1, 2-propanodicarboxylic acid (99mTc-DPD) for early detection of cardiac amyloid deposition and prediction of clinical worsening in subjects carrying a transthyretin gene mutation 72
Differentiated thyroid carcinoma in lingual thyroid 71
Peptide Receptor Radionuclide Therapy and Somatostatin 'cold' Analogues Therapy in the Treatment of GEP-NET Patients: Our Center’ Experience 71
Peptide receptor radionuclide therapy with 111IN-DTPA-Octreotide in a woman with Cabergoline-resistant giant prolactinoma 70
Recurrent bladder carcinoma: clinical and prognostic role of 18 F-FDG PET/TC 70
11c-choline pet/ct based helical tomotherapy as treatment approach for bone metastases in recurrent prostate cancer patients 70
Parathyroid carcinoma presenting as normocalcemic hyperparathyroidism 70
Recombinant erythropoietin and hypertension 69
Thyroid remnant ablation in differentiated thyroid cancer: searching for the most effective radioiodine activity and stimulation strategy ina real life scenario 69
Braf V600E and 99m-TC MIBI scintigraphy are usefull diagnostic tools in identifying metastatic differentiated thyroid cancer patients refractory to radioiodine therapy. 69
Meningocele due to closed spina bifida mimicking a metastasis of papillary thyroid carcinoma on whole body radioactive iodine scan 69
Role of MIBI-99mTc scan in detecting local and distant metastases of differentiated thyroid cancer immediately after total thyroidectomy 68
The 14CO2 urea breath test for Helicobacter pylori infection 68
A Monte Carlo approach to small-scale dosimetry of solid tumour microvasculature for nuclear medicine therapies with (223)Ra-, (131)I-, (177)Lu- and (111)In-labelled radiopharmaceuticals 68
99mTc-MIBI SPECT imaging of acute and subacute non-neoplastic brain haematomas 67
Increased 177Lu-DOTATATE Uptake in Paget Disease 67
Can the position of malignant thyroid nodule be considered as additional risk factor for recurrent and/or metastatic disease in patients affected by low risk differentiated thyroid cancer? 67
Usefulness of PET-CT scan in recurrent thyroid cancer 67
Safety, effectiveness and haematological toxicity of 223Radichloride: a single Centre experience 67
Central nervous system vasculitis after starting methimazole in a woman with Graves' disease 67
Studio della perfusione cerebrale nell'idrocefalo in eta' pediatrica 66
GASTROINTESTINAL SEQUELAE IN SURVIVORS OF CONGENITAL DIAPHRAGMATIC HERNIA 66
Association of autonomously functioning ("hot") thyroid nodules with Hashimoto's thyroiditis 66
Evaluation Of Absorbed Doses To Autonomous Thyroid Nodules During 131I Treatment Of Hyperthyroidism: Traditional Approach Versus Monte Carlo Calculation 66
99mTc-HM-PAO SPECT evaluation of regional cerebral blood flow modifications after paediatric hydrocephalus shunting 66
99mTc-MIBI SPECT in the differential diagnosis of brain metastases 66
2 years-survival analysis of patients with non-small cell lung cancer by means of 2deoxy-2-[18F]fluoro-D-glucose positron emission tomography: implications of maximum standardized uptake value (SUVmax) 66
Usefulness of Combining Electrocardiographic and Echocardiographic Findings and Brain Natriuretic Peptide in Early Detection of Cardiac Amyloidosis in Subjects With Transthyretin Gene Mutation 66
Conservative treatment in primary neonatal megaureter 65
Iodine-131 treatment of hyperthyroidism: our experience 65
Association of autonomously functioning thyroid nodules with Hashimoto’s thyroiditis: study on a large series of patients 65
186Re-HEDP in the treatment of painful bone metastases from cancers other than prostate and breast 65
Hyperthyroidism treatment with calculated activity of 131-Radioiodine: our experience 65
99mTc-methoxy-isobutyl-isonitrile (MIBI) scintigraphy is an useful and cost-effective tool for assessing the risk of malignancy in thyroid nodules with indeterminate fine needle cytology (FNAC) 65
Complete Response in a Pancreatic Nen with Liver Metastasis after PRRT in association with Lanreotide Autogel/depot: Design of the Prelude Study 65
A model to evaluate S values for beta-gamma emitting radionuclides in cubic voxels 64
Peptide Receptor Radionuclide Therapy in Patients with Inoperable Meningiomas: Our Experience and Review of the Literature 64
Emerging role of Radium-223 in the growing therapeutic armamentarium of metastatic castration-resistant prostate cancer 64
Effectiveness, safety and haematological toxicity of 223Ra-Cl2: a single centre experience 64
The role of 99mTc-Sestamibi SPET in the preoperative management and differential diagnosis of cerebral lesions 63
BONE-SCAN IN PATIENT WITH HORSESHOE-KIDNEY MIMICKING SKELETAL LUMBAR METASTASIS 63
Association of primary hyperparathyroidism (p-hyperPTH) with nodular toxic goiter (NTG) 63
90Y-dotatoc and/or 111In-pentetreotide in the treatment of somatostatin receptors-expressing tumors (SSTR): personal experience 63
ACCUMULO DI RADIOIODIO IN MIELOMENINGOCELE SECONDARIO A SPINA BIFIDA OCCULTA: PRIMA EVIDENZA DI CONDIZIONE SIMULANTE UNA METASTASI VERTEBRALE DI CARCINOMA DIFFERENZIATO DELLA TIROIDE 63
Scintigraphic evaluation of colonic motility in patients with anorectal malformations 63
Associazione tra noduli tiroidei iperfunzionanti (noduli "caldi") e tiroidite di Hashimoto 62
Erratum: Mid and long-term effects on pulmonary perfusion, anatomy and diaphragamatic motility in survivors of congenital diaphragmatic hernia 62
Short-term effectiveness of low-dose radioiodune ablative treatment of thyroid remnants after thyroidectomy for differentiated thyroid cancer 62
Trattamento dell'ipertiroidismo con attività di radioiodio calcolata per singolo paziente (dosimetria personalizzata). 62
Peptide receptor imaging in neuroendocrine tumors: comparison between diagnostic scintigraphy and post-therapy whole-body scan 62
Differentiating malignant from benign thyroid nodules with indeterminate cytology by 99mTc-MIBI scan: A new quantitative method for improving diagnostic accuracy 62
Is malignant nodule topography an additional risk factor for metastatic disease in low-risk differentiated thyroid cancer? 62
Dual Time-Point FET-PET/CT in Glioma Patients: a Single-Centre Preliminary Experience 62
[68 Ga]DOTATOC PET/CT Radiomics to Predict the Response in GEP-NETs Undergoing [177 Lu]DOTATOC PRRT: The “Theragnomics” Concept 62
THE TREATMENT OF LARGE SUPRATENTORIAL ARACHNOID CYSTS IN INFANTS WITH CYST-PERITONEAL SHUNTING AND HAKIM PROGRAMMABLE VALVE 61
Hepatobiliary imaging in a patient with liver abscess: interesting diagnostic findings 61
Reversible cerebral perfusion alterations in children with transient mutism after posterior fossa surgery 61
153Sm-EDTMP in the treatment of painful bone metastases from prostate and breast cancer. Personal experience. 61
Megauretere primitivo. Indagini diagnostiche, protocolli diagnostici 61
L'azione di un bolo di rHu-EPO sul flusso muscolare di soggetti uremici 61
Peptide receptor radionuclide therapy for aggressive pituitary tumors: a monocentric experience 61
Absorbed fractions for photons in ellipsoidal volumes 60
RUOLO DEL LEUKOSCAN NELLA DIAGNOSI DELLA SPONDILODISCITE BRUCELLARE 60
Totale 9.213
Categoria #
all - tutte 104.727
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 104.727


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20202.287 0 0 0 102 23 404 338 297 74 543 416 90
2020/20212.740 254 28 620 148 242 240 43 124 119 268 283 371
2021/20223.465 47 468 49 110 154 34 199 177 39 521 483 1.184
2022/20239.159 747 987 441 737 699 918 131 503 3.615 61 226 94
2023/20243.493 196 332 205 285 247 655 144 232 104 419 209 465
2024/20251.243 322 295 400 226 0 0 0 0 0 0 0 0
Totale 24.986